Novo Integrated Sciences Gross Profit 2012-2024 | NVOS

Novo Integrated Sciences gross profit from 2012 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Novo Integrated Sciences Annual Gross Profit
(Millions of US $)
2023 $5
2022 $5
2021 $4
2020 $3
2019 $4
2018 $3
2017 $3
2016 $
2016 $3
2015 $
2014 $
2013 $
2012 $
2012 $
2011 $
2011 $
Novo Integrated Sciences Quarterly Gross Profit
(Millions of US $)
2024-02-29 $1
2023-11-30 $2
2023-08-31 $1
2023-05-31 $1
2023-02-28 $1
2022-11-30 $2
2022-08-31 $-0
2022-05-31 $2
2022-02-28 $1
2021-11-30 $1
2021-08-31 $1
2021-05-31 $1
2021-02-28 $1
2020-11-30 $1
2020-08-31 $1
2020-05-31 $0
2020-02-29 $1
2019-11-30 $1
2019-08-31 $1
2019-05-31 $1
2019-02-28 $1
2018-11-30 $1
2018-08-31 $1
2018-05-31 $1
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $1
2017-03-31
2017-02-28 $1
2016-12-31
2016-11-30 $1
2016-09-30
2016-06-30
2016-05-31 $1
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.014B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.800B 0.00
Quest Diagnostics (DGX) United States $15.206B 15.72
DaVita (DVA) United States $12.153B 15.10
Encompass Health (EHC) United States $8.638B 22.11
Chemed (CHE) United States $8.214B 25.46
Elanco Animal Health (ELAN) United States $7.131B 18.50
Option Care Health (OPCH) United States $4.815B 18.22
RadNet (RDNT) United States $4.353B 90.65
Amedisys (AMED) United States $3.000B 21.25
Astrana Health (ASTH) United States $2.272B 30.73
Addus HomeCare (ADUS) United States $1.901B 27.19
LifeStance Health (LFST) United States $1.877B 0.00
U.S Physical Therapy (USPH) United States $1.393B 37.27
Pennant (PNTG) United States $0.697B 36.81
Aveanna Healthcare Holdings (AVAH) United States $0.531B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00